B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged immune cells take on resistant blood cancers
Disease control Not yet recruitingThis early-phase trial tests a new treatment for people with certain blood cancers (lymphomas and leukemias) that have not responded to standard therapies. The treatment uses specially engineered natural killer (NK) cells from donated cord blood, designed to better target cancer …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
New combo therapy aims to tackle tough leukemia
Disease control Not yet recruitingThis study tests whether combining two drugs, inotuzumab and blinatumomab, is safe and works well for adults newly diagnosed with B-cell acute lymphoblastic leukemia (B-ALL). It includes people aged 18 and older who cannot have standard chemotherapy. The goal is to see if the tre…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
New hope for cancer survivors: drug aims to shield against Life-Threatening infections
Disease control Not yet recruitingThis study tests a drug called IgPro20 in 63 adults who have a weakened immune system after receiving CAR T-cell therapy for blood cancers like lymphoma or multiple myeloma. The goal is to see if the drug can lower the number of serious bacterial infections, such as pneumonia or …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
New bedside CAR-T treatment aims to tackle blood cancer in adults
Disease control Not yet recruitingThis early-phase study tests a personalized CAR-T cell therapy made at the bedside for adults with B-cell acute lymphoblastic leukemia. The treatment uses the patient's own immune cells to target and kill cancer cells. The main goals are to check safety, find the best dose, and s…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: EARLY_PHASE1 • Sponsor: The General Hospital of Western Theater Command • Aim: Disease control
Last updated Jun 18, 2026 11:50 UTC
-
Strength training for kids with leukemia: a new way to fight fatigue?
Symptom relief Not yet recruitingThis study tests whether a 9-week strength training program using resistance bands and bodyweight exercises is practical for children aged 6 to 21 with newly diagnosed acute lymphoblastic leukemia or lymphoma. The program includes both in-person and virtual sessions, with weekly …
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 23, 2026 11:59 UTC
-
Italian study to track CAR-T success in leukemia patients
Knowledge-focused Not yet recruitingThis observational study will follow 107 children and adults with B-cell acute lymphoblastic leukemia who are treated with approved CAR-T cell therapies in Italy. Researchers will collect data from medical records to see how many patients achieve a response. The goal is to unders…
Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:59 UTC